NR1I2 and metabolic disease: Although NR1I2 and NR1I3 are xenobiotic receptors investigated in cancer, drug interaction, obesity, and metabolic diseases (Chai et al. 2013; Gao and Xie 2012), in the present study we infer a potential connectivity with many of the MRDT chemicals.